- The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.
The result was soft delete. Based on minimal participation, this uncontroversial nomination is treated as an expired PROD (a.k.a. "soft deletion"). Editors can . ✗plicit 00:45, 17 December 2023 (UTC)
Vion Pharmaceuticals
[Hide this box] New to Articles for deletion (AfD)? Read these primers!
- Vion Pharmaceuticals (edit | talk | history | protect | delete | links | watch | logs | views) – (View log | edits since nomination)
- (Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)
WP:MULTSOURCES - one source for its bankruptcy alone is not notable, nor did the experimental drugs ever leave trial stage. Cannot find any other sources. Darcyisverycute (talk) 13:44, 3 December 2023 (UTC)
- Note: This discussion has been included in the deletion sorting lists for the following topics: Companies and Medicine. Darcyisverycute (talk) 13:44, 3 December 2023 (UTC)
- Note: This discussion has been included in the list of Connecticut-related deletion discussions. Shellwood (talk) 13:48, 3 December 2023 (UTC)
Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, Liz Read! Talk! 08:13, 10 December 2023 (UTC)
- Delete: An article created then later updated by the WP:SPA VPInc regarding the progress of their drug trials then in progress. The FDA rejection and subsequent Chapter 11 bankruptcy of the firm do not provide attained notability. AllyD (talk) 17:13, 10 December 2023 (UTC)
- The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.